| ²é¿´: 1116 | »Ø¸´: 1 | |||
06113021zjh½ð³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
Çó·ÒëÖвÝÒ©·½ÃæÉó¸åÈËÒâ¼û ÒÑÓÐ1È˲ÎÓë
|
|
°ïÅóÓÑͶÁËһƪҩÎïÏ໥×÷ÓõÄÎÄÕ£¬ÏÖÔÚÐ޻أ¬ÓÉÓÚСµÜ¶ÔÖÐÒ©Õâ¿é²»Ì«ÁË½â£¬ÌØ´ËÇóÖúÉó¸åÈ˵ÄÒâ¼ûÊÇʲôÒâ˼£¬ÐÞ»ØÐèÒª×öµ½ÄÄЩ£¬×îºÃÄÜ·Òëһϣ¬Íò·Ö¸Ðл£¡ 1.The manuscript stil is not in line with acceptance cryteria outlined in Guides ro Authors update. * Herbal medicinal products (HMP) or herbal preparations (HP) must be declared in accordance to EMA guidelines (http://www.ema.europa.eu/docs/en ... 9/WC500003272.pdf). In particular, preparation of herbal extracts must be clearly and comprehensively described with respect to the plant part used, the drug extract ratio, type and concentration of extraction solvent, extraction conditions etc. They must be sufficiently characterized (e.g. by appropriate TLC and/HPLC fingerprints, for further information see for example. http://www.springer.com/biomed/p ... 762-1?changeHeader) and quantified for the content of marker compounds to ensure a consistent quality and reproducible pharmacological activity. The choice of marker must be justified. The analytical methods have to be validated and briefly described, providing the most important information necessary to obtain reproducible results. * For multiherbal drug combinations (Herbal Drug Formula): Each single herbal drug from any drug combination (formula) must undergo the same authentication and standardization process as described above. Additionally, a total HPLC-profile of the multiherbal drug combination using 3-D-HPLC-technique and including identification of main ("marker" compounds must also be supplied for a model of 3D-HPLC-analysis of a multidrug combination, see: Amagaya S. et al. 2001, Phytomedicine 8: 338-347 http://www.sciencedirect.com/sci ... i/S0944711304700495 ; For TCM-multi-herbal drug combinations (formula) see: Zeng K.-W. et al. 2012, Phytomedicine 19, 122-129. http://www.sciencedirect.com/sci ... i/S0944711311002674Additionally, some other relevant and justified physiological, biological, or biochemical methods can be used to ensure reproducible pharmacological activity of multi-herbal drug combinations. * Plant name and part(s) used . Botanically accepted Latin binominals with authorities together with the botanical species, subspecies or synonyms must be provided for all plants. In the text it should be stated that the plant name has been checked with www.theplantlist.org. The parts used in the study should be specified The authentication of fresh plants or dried herbal drugs, including those of formulas, must be carried out by means of macroscopic and/or microscopic, moleclularbiological, chemical, chromatographic and/or other suitable pharmacognostic methods. Voucher specimens of plant materials used for all studies must be deposited and identified with a voucher number, the date and location of collection. |
» ²ÂÄãϲ»¶
Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
265Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
085700×ÊÔ´Óë»·¾³308Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
Ò»Ö¾Ô¸¼ªÁÖ´óѧ²ÄÁÏѧ˶321Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
286·ÖÈ˹¤ÖÇÄÜרҵÇëÇóµ÷¼ÁÔ¸Òâ¿ç¿¼£¡
ÒѾÓÐ3È˻ظ´
329Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
ÉêÇë»Ø¸åÑÓÆÚÒ»¸öÔ£¬±à¼Í¬ÒâÁË¡£µ«ÏµÍ³ÉϵÄʱ¼äû±ä£¬¸ø±à¼ÓÖдÓʼþÁË£¬Ã»»Ø¸´
ÒѾÓÐ4È˻ظ´
²ÄÁÏѧ˶318Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸Öйúº£Ñó´óѧ£¬ÉúÎïѧ£¬301·Ö£¬Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
081700»¯¹¤Ñ§Ë¶µ÷¼Á
ÒѾÓÐ3È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÂÛÎÄ»ØÐÅÓÐÕâôһ¾ä»°£¬Çó¸÷λ´óÉñ°ïæ·ÒëÒ»ÏÂÉó¸åÈËÕâ¾ä»°ÊÇʲôÒâ˼
ÒѾÓÐ17È˻ظ´
ÂÛÎı¾ßÉ£ÐÄ~ ÇóÍÆ¼ö¼ÆËã»ú·½ÃæÉó¸å½Ï¿ìµÄEIÆÚ¿¯£¨Ð»Ð»´ó¼ÒÀ²£¡£©
ÒѾÓÐ11È˻ظ´
Éó¸åÈËÒâ¼û·Òë
ÒѾÓÐ5È˻ظ´
Ͷanal chim acta±»¾Ü£¬ÆäÖÐÒ»Éó¸åÈËÒâ¼ûÓе㲻Ã÷°×£¬Çë´ó¼Ò°ïæ·ÒëÏ£¡
ÒѾÓÐ5È˻ظ´
ÇëÎÊÒ»¸öÓ¢ÎÄÔÓÖ¾£¬Èç¹ûÉó¸åÒâ¼ûÊÇÖÐÎÄ£¬ÎÒÓ¦¸ÃÊÇÓ¢ÎÄ»¹ÊÇÖÐÎĻظ´Éó¸åÒâ¼ûÄØ
ÒѾÓÐ11È˻ظ´
Éó¸åÒâ¼û»Ø¸´ÇóÖú
ÒѾÓÐ6È˻ظ´
Ó¢ÎÄÉó¸åÒâ¼û²»ÖªÈçºÎ»Ø¸´£¬ÇóÖú£¡¼±
ÒѾÓÐ6È˻ظ´
ÇóÖú Ôõô»Ø¸´Éó¸åÒâ¼û
ÒѾÓÐ8È˻ظ´
Éó¸åÈ˵ÄÒ»¸öÎÊÌ⣬´ó¼Ò°ïæ·ÒëÒÔÏÂ
ÒѾÓÐ6È˻ظ´
Éó¸åÒâ¼ûÈçºÎ»Ø¸´£¬ÇóÖú
ÒѾÓÐ4È˻ظ´
ÖвÝÒ©ÔÓÖ¾µÄƽ¾ùÉó¸åÆÚ¶à³¤
ÒѾÓÐ3È˻ظ´
ÇóJournal of Medicinal Plants Research Ͷ¸å¹ý³Ì
ÒѾÓÐ13È˻ظ´
ÖйúÖÐÒ©ÔÓÖ¾Éó¸åʱ¼ä
ÒѾÓÐ6È˻ظ´
Éó¸åר¼ÒµÄÁ½¸öÒâ¼û£¬Ó¢Óï±È½Ï²î£¬¿´µÃ²»ÊǺÜÃ÷°×¡£ÇóÖú£¡
ÒѾÓÐ3È˻ظ´
ÇóÖúͶ¸åÒâ¼û»Ø¸´
ÒѾÓÐ10È˻ظ´
×Ô˽µÄè1988
ÈÙÓþ°æÖ÷ (ÎÄ̳¾«Ó¢)
- Ó¦Öú: 4800 (¸±½ÌÊÚ)
- ¹ó±ö: 6.746
- ½ð±Ò: 50040.4
- É¢½ð: 11517
- ºì»¨: 256
- ɳ·¢: 134
- Ìû×Ó: 11684
- ÔÚÏß: 1473.7Сʱ
- ³æºÅ: 2004083
- ×¢²á: 2012-09-16
- ÐÔ±ð: GG
- רҵ: Óлú·Ö×Ó¹¦ÄܲÄÁÏ»¯Ñ§
- ¹ÜϽ: ÂÛÎÄͶ¸å
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ...
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
06113021zjh: ½ð±Ò+60, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, лл 2014-11-03 19:16:05
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
06113021zjh: ½ð±Ò+60, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, лл 2014-11-03 19:16:05
|
1.The manuscript stil is not in line with acceptance cryteria outlined in Guides ro Authors update. Îĸ廹δ´ïµ½ÆÚ¿¯ÒªÇó½ÓÊյıê×¼ * Herbal medicinal products (HMP) or herbal preparations (HP) must be declared in accordance to EMA guidelines (http://www.ema.europa.eu/docs/en ... 9/WC500003272.pdf). Õâ¸ö¹À¼ÆÊDZê×¼ In particular, preparation of herbal extracts must be clearly and comprehensively described with respect to the plant part used, the drug extract ratio, type and concentration of extraction solvent, extraction conditions etc. They must be sufficiently characterized (e.g. by appropriate TLC and/HPLC fingerprints, for further information see for example. http://www.springer.com/biomed/p ... 762-1?changeHeader) and quantified for the content of marker compounds to ensure a consistent quality and reproducible pharmacological activity. ÌáÈ¡ÎïµÄÖÆ±¸·½·¨ÐèÒªºÜÃ÷È·ÏêϸµØÌáÈ¡×ÔÖ²ÎïµÄÄIJ¿·Ö£¬ÌáÈ¡ÈܼÁµÄ±ÈÀý£¬ÀàÐͺÍŨ¶È£¬ÒÔ¼°ÌáÈ¡µÄÌõ¼þ¡£¶øÇÒÐèÒª±íÕ÷£¨ÀýÈçTLCºÍHPLC¼ì²âµÈµÈ£©ºÍÁ¿»¯Ä¿±ê»¯ºÏÎïµÄ¾ßÌ庬Á¿£¬ÒÔ±£Ö¤Ò»ÖµÄÖÊÁ¿ºÍ¿ÉÖØ¸´ÐÔµÄÒ©Àí»îÐÔ¡£ The choice of marker must be justified. The analytical methods have to be validated and briefly described, providing the most important information necessary to obtain reproducible results. ±êʶÎïµÄÑ¡ÔñÐèÒªÌṩÒÀ¾Ý£¬·ÖÎö·½·¨¾¹ýÑéÖ¤¡¢¼òµ¥ÃèÊö£¬²¢ÌṩµÃµ½Öظ´½á¹ûµÄ±ØÒª¹Ø¼üÐÅÏ¢¡£ *For multiherbal drug combinations (Herbal Drug Formula): Each single herbal drug from any drug combination (formula) must undergo the same authentication and standardization process as described above. Additionally, a total HPLC-profile of the multiherbal drug combination using 3-D-HPLC-technique and including identification of main ("marker" compounds must also be supplied for a model of 3D-HPLC-analysis of a multidrug combination, see: Amagaya S. et al. 2001, Phytomedicine 8: 338-347 http://www.sciencedirect.com/sci ... i/S0944711304700495 ; For TCM-multi-herbal drug combinations (formula) see: Zeng K.-W. et al. 2012, Phytomedicine 19, 122-129. http://www.sciencedirect.com/sci ... i/S0944711311002674 ¶ÔÓÚ¶à¸öÒ©×éºÏ£¬Ã¿¸ö¶¼ÐèÒªÉÏÊöµÄ¼ø¶¨ºÍ±ê×¼»¯¹ý³Ì¡£´ËÍ⣬×éºÏµÄ×ÜÌåHPLCÊý¾ÝÒ²ÐèÒªÌṩ£¨Í¨¹ý3-D-HPLC¼¼Êõ£©£¬²¢ÇÒ±êʶÖ÷ÒªµÄ³É·Ö£¨Ïêϸ·½·¨¼û¡£¡£¡£¡££© Additionally, some other relevant and justified physiological, biological, or biochemical methods can be used to ensure reproducible pharmacological activity of multi-herbal drug combinations. ÁíÍâÆäËûÏà¹ØÖØ¸´¸Ã×éºÏҩѧ»îÐÔµÄÉúÀíѧ¡¢ÉúÎïѧºÍÉú»¯·½·¨Ò²ÐèÒªÌṩ * Plant name and part(s) used . Botanically accepted Latin binominals with authorities together with the botanical species, subspecies or synonyms must be provided for all plants. In the text it should be stated that the plant name has been checked with www.theplantlist.org. The parts used in the study should be specified Ö²ÎïÃû³ÆºÍʹÓò¿·Ö¡£ÌṩËùÓÐʹÓõÄÖ²ÎïµÄË«ÃûÖÆÀ¶¡Ãû³ÆºÍ±È½ÏȨÍþµÄÖ²ÎïÖÖ¡¢ÑÇÖÖ»ò±ðÃû¡£Í¬Ê±×¢Ã÷Ö²ÎïÃû³ÆÔÚÍøÕ¾Öмì²é¹ý¡£ËùʹÓõIJ¿·Ö±ØÐë¾ßÌ廯¡£ The authentication of fresh plants or dried herbal drugs, including those of formulas, must be carried out by means of macroscopic and/or microscopic, moleclularbiological, chemical, chromatographic and/or other suitable pharmacognostic methods. ÐÂÏʵÄÖ²Îï»òÕ߸ɵIJÝÒ©£¬°üÀ¨Åä·½Àï°üº¬µÄ£¬ÐèҪͨ¹ýºê¹Û»ò΢¹Û¡¢·Ö×ÓÉúÎïѧ¡¢»¯Ñ§¡¢É«Æ×ѧÒÔ¼°ÆäËûÉúҩѧµÄ·½·¨¼ø¶¨ Voucher specimens of plant materials used for all studies must be deposited and identified with a voucher number, the date and location of collection. ËùʹÓÃÑо¿Ö²Îï²ÄÁÏµÄÆ¾Ö¤±ê±¾ÐèÒª´æ·ÅºÍ¼ø¶¨µÃµ½Ò»¸ö±àºÅ¡¢ÈÕÆÚºÍ´æ·ÅµØµã¡£ ¸ö±ð´Ê»ã¿ÉÄÜÓвî´í£¬×ÔÐÐÕå×à |
2Â¥2014-11-02 11:23:01













compounds must also be supplied for a model of 3D-HPLC-analysis of a multidrug combination, see: Amagaya S. et al. 2001, Phytomedicine 8: 338-347
»Ø¸´´ËÂ¥